Elidah, Inc. — SEC Form D Filing

Elidah, Inc. filed an SEC Form D on April 3, 2026, reporting $2.02M raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
April 3, 2026
Amount reported
$2.02M
Round stage
Seed
Industry
Health Technology
Website
https://elitone.com/

What the company does

Securities: Equity. Revenue: $5,000,001 - $25,000,000. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Many women experience bladder leaks, which can affect their daily lives and confidence.

Solution

Elitone provides a clinical-grade pelvic floor therapy device for home use to help women address the root cause of bladder leaks.

Why now

There is a growing awareness and need for non-invasive treatments for pelvic health issues, especially among women.

Verdict

Investors said yes at this moment because Elidah presented a timely solution to a longstanding issue affecting many women, effectively framing the narrative around a growing demand for discreet, home-based health solutions. They were implicitly betting on the expanding acceptance of women's health innovations coupled with a shift towards at-home therapies. However, the limited upside stems from potential competition in a soon-crowded market, which could dilute differentiation; this cleared because the focus on women's physical health resonated, not because the product offered groundbreaking technology.

Source: SEC EDGAR Form D filing